News about Industrial talks

Akums Signs MoU with Sharda University Agra to Advance Pharma Research

Akums Drugs & Pharmaceuticals has entered into a Memorandum of Understanding (MoU) with Sharda University, Agra, to collaborate on pharmaceutical research, technology transfer, and skill development, with an emphasis on strengthening the linkage between academic research and industrial application.

Industrial talks | 29/12/2025 | By Darshana

WHO and AYUSH Ministry Hold Technical Meet on Integrating AYUSH into Global Health Standards

WHO and Ministry of AYUSH held a technical meeting to advance the integration of Ayurveda, Siddha and Unani (ASU) systems into global health standards, laying the groundwork for a Traditional Medicine (TM) module within the International Classification of Health Interventions (ICHI), with India supporting the required financial and technical frameworks.

Industrial talks | 22/12/2025 | By News Bureau

WHO Hosts 2nd Global Summit to Promote Innovation and Integration in Traditional Medicine

The World Health Organization’s second Global Summit on Traditional Medicine has convened global leaders, scientists and indigenous practitioners from over 100 countries, with key scientific initiatives and new commitments expected to advance the WHO Global Traditional Medicine Strategy 2025–2034.

Industrial talks | 19/12/2025 | By News Bureau

Lupin's Climate Targets Across All Emission Scopes Validated by SBTi

Global pharmaceutical major Lupin Limited has announced that its greenhouse gas emissions reduction targets have been officially validated by the Science Based Targets initiative. The validation covers Scope 1, Scope 2 and Scope 3 emissions, aligning Lupin’s climate strategy with the Paris Agreement goal of limiting global temperature rise to 1.5°C.

Industrial talks | 16/12/2025 | By Darshana

Indoco Receives USFDA EIR for Patalganga API Manufacturing Facility

Indoco has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its API manufacturing facility at Patalganga following an inspection conducted in the month of September.

Industrial talks | 15/12/2025 | By News Bureau

Jubilant Pharmova Appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics

Jubilant Pharmova has announced the appointment of Daniel J. O’Connor as CEO of its proprietary novel drugs business, Jubilant Therapeutics Inc.

Industrial talks | 02/12/2025 | By Dineshwori

Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions

Tsingke Biotech showcased its accelerated protein and antibody production platform at PEGS Europe 2025, announcing capabilities to generate proteins in as little as three days and antibodies within seven—offering a boost to biopharma developers seeking faster drug discovery timelines.

Industrial talks | 20/11/2025 | By Dineshwori

Merus, Halozyme Partner to Develop Subcutaneous Petosemtamab

Under the agreement, Merus will pay Halozyme upfront and milestone-based payments, with Halozyme also eligible for low- to mid-single-digit royalties on future ENHANZE-enabled petosemtamab sales.

Industrial talks | 19/11/2025 | By Dineshwori

Health Minister Marks AMRIT Pharmacy's 10th Anniversary, Announces Nationwide Expansion

AMRIT pharmacies offer medicines at discounts of around 50 percent, benefiting more than 6.85 crore patients to date. Medicines valued at over INR 17,000 crore have been dispensed through the network, resulting in cumulative patient savings of approximately INR 8,400 crore, according to the data shared.

Industrial talks | 17/11/2025 | By Dineshwori

Pfizer Completes Acquisition of Metsera

Pfizer has finalised its acquisition of Metsera, adding a portfolio of differentiated, clinical-stage obesity therapies with the potential to redefine future treatment standards. The deal strengthens and reshapes Pfizer’s internal medicine portfolio, positioning the company to compete more aggressively in therapeutic areas, globally.

Industrial talks | 14/11/2025 | By Dineshwori